Compare BBSI & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBSI | CBLL |
|---|---|---|
| Founded | 1965 | 2014 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 748.3M | 750.1M |
| IPO Year | 1994 | N/A |
| Metric | BBSI | CBLL |
|---|---|---|
| Price | $30.68 | $20.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $42.67 | $23.20 |
| AVG Volume (30 Days) | 132.7K | ★ 214.5K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 5.05 | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $920,432,000.00 | N/A |
| Revenue This Year | $6.59 | $29.57 |
| Revenue Next Year | $6.05 | $28.44 |
| P/E Ratio | $15.10 | ★ N/A |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $25.33 | $10.85 |
| 52 Week High | $49.65 | $24.33 |
| Indicator | BBSI | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 53.00 |
| Support Level | $29.54 | $18.78 |
| Resistance Level | $37.37 | $21.80 |
| Average True Range (ATR) | 0.63 | 0.77 |
| MACD | 0.16 | -0.07 |
| Stochastic Oscillator | 53.26 | 48.66 |
Barrett Business Services Inc is a provider of business management solutions for small and mid-sized companies through a platform that combines management consulting expertise with human resource tools to help business owners manage and operate their businesses more effectively. The company has two categories of services: Professional Employer Services (PEO) and Staffing. The majority of revenue is derived from the Professional Employer Services segment, which provides clients with human resource advisory services, HRIS access, retirement plans, a learning management system, and a web-based technology platform, myBBSI.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.